A Multi-Laboratory, Multi-Platform Analysis of the Multi-Attribute Method
Pharmaceuticals · 25.10.2025 · 18 (11) · 1613
DOI: 10.3390/ph18111613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 25.10.2025. Verfasst von Joshua Shipman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Office of Pharmaceutical Quality Research, Center for Drug Evaluation and Research, US Food and Drug Administration, Saint Louis, MO 63110, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The multi-attribute method (MAM) has found diverse use in the analytical characterization of therapeutic protein products during their development and production. As the MAM matures it has the potential to enter quality control (QC) laboratories, consolidating and replacing many less informative chromatographic techniques; however, this requires an appropriate risk assessment and understanding of method capability.
Methods
A validated MAM approach was used to quantify product quality attributes (PQAs) using three different mass spectrometers across two laboratories; the results were compared to conventional hydrophilic interaction chromatography–fluorescence detection (HILIC-FLD) and cation exchange chromatography–ultraviolet (CEX-UV) techniques.
Results
Stressed, long-term, and accelerated stability studies were performed, and their effects on glycosylation, deamidation, oxidation and N- and C-termini were quantified.
Conclusions
Overall, the inter-instrument inter-laboratory data provided here showed important considerations for transferring methods between laboratories and establishing the correlation between the MAM and conventional data, elements which are necessary to transition the MAM to the QC environment and ultimately achieving the goal of replacing orthogonal QC methods.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Pharmaceutical Quality Research, Center for Drug Evaluation and Research, US Food and Drug Administration, Saint Louis, MO 63110, USA.
- Office of Product Quality Assessment, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20903, USA.
- BridgeBio, Palo Alto, CA 94304, USA.
- Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD 20903, USA.
ORCID-Profile: Joshua Shipman, Sarah Rogstad
Zitieren
APA
Shipman, J., Oyugi, M., Marzan, T. A., Geerlof-Vidavsky, I., Kirkpatrick, D., Zhu, H., Rasangika, M., & Rogstad, S. (2025). A Multi-Laboratory, Multi-Platform Analysis of the Multi-Attribute Method. Pharmaceuticals, 18(11), 1613. https://doi.org/10.3390/ph18111613
Vancouver
Shipman J, Oyugi M, Marzan TA, Geerlof-Vidavsky I, Kirkpatrick D, Zhu H, et al. A Multi-Laboratory, Multi-Platform Analysis of the Multi-Attribute Method. Pharmaceuticals. 2025;18(11):1613. doi:10.3390/ph18111613
BibTeX
@article{Shipman2025,
author = {Shipman, Joshua and Oyugi, Mercy and Marzan, Tim Andres and Geerlof-Vidavsky, Ilan and Kirkpatrick, Douglas and Zhu, Hongbin and Rasangika, Milani and Rogstad, Sarah},
title = {A Multi-Laboratory, Multi-Platform Analysis of the Multi-Attribute Method},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {11},
pages = {1613},
doi = {10.3390/ph18111613}
}
EUVIMED